Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Rheumatology|September 1, 1991
Malignant lymphoma in systemic rheumatic diseases. A report of five casesF A Houssiau, C Kirkove, R A Asherson, et al.
Leukemia & Lymphoma|May 9, 2001
18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CTN G Mikhaeel, A R Timothy, M J O'Doherty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 29, 1998
Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastasesO S Nielsen, S M Bentzen, E Sandberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2005
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphomaN G Mikhaeel, M Hutchings, P A Fields, et al.
British Medical Journal|May 13, 1978
Radiotherapy in the treatment of Hodgkin's diseaseA R Timothy, S B Sutcliffe, A G Stansfeld, et al.
Lymphatic Research and Biology|December 31, 2004
Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedemaA W B Stanton, R H Mellor, G J Cook, et al.
British Journal of Cancer|September 6, 2000
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapseS F Hain, M J O'Doherty, A R Timothy, et al.
European Journal of Nuclear Medicine|June 15, 2000
Fluorodeoxyglucose PET in the initial staging of germ cell tumoursS F Hain, M J O'Doherty, A R Timothy, et al.
Blood|May 23, 1998
Detection of lymphoma in bone marrow by whole-body positron emission tomographyR Carr, S F Barrington, B Madan, et al.
Pageof 6